Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Parabolic Drugs IPO.
June 24, 2024 3:55:00 PM
Foresite Capital Management, Baker Brothers Life Sciences LP and AyurMaya Capital Management Fund LP are listed as principal shareholders in the Alumis IPO. Why Intel�s stock avoided the ...
Published by : MarketWatchJuly 17, 2024 8:15:00 AM
Actuate Therapeutics has set out plans for a modest $52 million IPO as the biotech seeks to fund a pair of trials for its glycogen synthase kinase-3 beta (GSK-3�) drug. The Texas- and Ireland-based ...
Published by : FierceBiotechJuly 18, 2024 11:11:00 PM
The offering comes days after the publication of a paper showing what analysts said was early proof that �off-the-shelf� cell therapies can treat inflammatory diseases.
Published by : BioPharma DiveJuly 14, 2024 12:55:00 PM
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Published by : The Motley Fool on MSNJune 24, 2024 3:30:00 AM
The company plans on starting a late-stage clinical trial of its drug in the second half of this year in psoriasis patients. Alumis Inc., a South San Francisco biotech company looking to take an ...
Published by : The Business JournalsJuly 15, 2024 3:30:00 AM
Calliditas Therapeutics has just pulled off the largest biotech IPO in Europe this year and is using it to bring a drug for a rare kidney disease to market. Richard Staines caught up with CEO ...
Published by : pharmaphorumJuly 8, 2024 7:57:10 PM
Akums Drugs and Pharmaceuticals has received Sebi approval to raise funds through an initial public offering (IPO), an update with the markets regulator showed on Monday ...
Published by : Press Trust of India on MSNJuly 17, 2024 3:31:00 AM
Aarti Drugs, RVNL, Phoenix Mills and more may remain under spotlight before the opening bell on Wednesday, July 10. The IPO of New Delhi-based Bansal Wire was open for bidding between July 03 ...
Published by : Business TodayJune 26, 2024 8:33:00 PM
This story has been updated to correct Lineage�s headquarters and number of employees. Lineage Inc. on Wednesday filed for an initial public offering as the largest temperature-controlled ...
Published by : MarketWatchJune 26, 2024 6:08:00 PM
Zorzal Inversiones Tecnologicas will become the first company in Uruguay to conduct an initial public offering in almost eight years this week, after authorities eased the rules on small companies ...
Published by : Bloomberg L.P.June 27, 2024 11:39:00 PM
Webtoon Entertainment Inc. shares climbed 9.5% in the online comics company�s debut after a US initial public offering that raised $315 million, priced at the upper end of a marketed range.
Published by : Bloomberg L.P.June 26, 2024 2:24:00 PM
Novi, Mich.-based Lineage has not yet disclosed an estimated price range or the number of shares in its IPO, but the deal has the makings of a very large stock offering due to the long list of ...
Published by : MorningstarIPO Listing Detail
Listing Date: Thursday, July 01, 2010
BSE Scrip Code: 533211
NSE Symbol: PARABOLIC
Listing In: 'B' Group of Securities
ISIN: INE618H01016
Issue Price: Rs. 75.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Parabolic Drugs Ltd IPO allotment status is now available online.
Parabolic Drugs IPO was open on Jun 14, 2010 and closed on Jun 17, 2010. IPO was oversubscribed by 1.04 times (0.4000 times in retail).
Parabolic Drugs Ltd IPO finally subscribed 1.04 times on its closing day. Parabolic Drugs Ltd IPO was open on Jun 14, 2010 and closed today on Jun 17, 2010 for subscription. Parabolic Drugs Ltd has received bids for 2,77,52,400 shares as against issue size of 2,66,66,667 shares.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.48 Times
Non Institutional Investors: 1.20 Times
Retail Individual Investors (RIIs): 0.40 Times
Employee: 0.11 Times
Total: 1.04 Times
Parabolic Drugs Limited is entering in the capital markets with an initial public offering, IPO of Rs. 200 Crore. The price band for the issue has not been decided yet.
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
The issue opens on Jun 14, 2010, and closes for subscription on Jun 17, 2010. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Parabolic Drugs IPO is proposed to open on June 14, 2010. The IPO application ends on June 17, 2010.
Retail investors can apply in the retail or non-institutional investor category from June 14, 2010 to June 17, 2010. The Parabolic Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Parabolic Drugs IPO will open for subscription on June 14, 2010. The public issue will close on June 17, 2010.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
